Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,534 | -2,613 | -8,822 | -6,749 | -4,641 |
| Depreciation Amortization | 354 | 176 | 723 | 546 | 370 |
| Accounts payable and accrued liabilities | 89 | 590 | -711 | -261 | -628 |
| Other Working Capital | 254 | 701 | -540 | -115 | -482 |
| Other Operating Activity | 1,000 | 422 | 1,137 | 593 | 830 |
| Operating Cash Flow | $-2,838 | $-724 | $-8,214 | $-5,986 | $-4,551 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -210 | -24 | -239 | -154 | -44 |
| Investing Cash Flow | $-210 | $-24 | $-239 | $-154 | $-44 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 16,564 | 16,564 | 10,442 |
| Other Financing Activity | -133 | -71 | -1,303 | -1,233 | -1,163 |
| Financing Cash Flow | $-133 | $-71 | $15,261 | $15,331 | $9,279 |
| Beginning Cash Position | 20,517 | 20,517 | 13,709 | 13,709 | 13,709 |
| End Cash Position | 17,336 | 19,697 | 20,517 | 22,900 | 18,393 |
| Net Cash Flow | $-3,181 | $-820 | $6,808 | $9,191 | $4,685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,838 | -724 | -8,214 | -5,986 | -4,551 |
| Capital Expenditure | -210 | -24 | -239 | -154 | -44 |
| Free Cash Flow | -3,048 | -749 | -8,453 | -6,140 | -4,595 |